2942
R. D. Ferguson et al. / Tetrahedron Letters 44 (2003) 2939–2942
11. IRORI MicroKans were each loaded with 30 mg Wang-
polystyrene resin (Novabiochem, 100–200 mesh, 1.30
mmol/g declared substitution), and then N-Fmoc-phenyl-
alanine was loaded onto the resin by using Sieber’s
2,6-dichlorobenzoyl chloride coupling method.15 Resin
loading by UV–vis spectroscopy (analysis of released
Fmoc-piperidine adduct at u=302 nm, m=8200 M−1
2H), 7.65 (m, 2H), 7.10–7.30 (m, 12H), 4.60 (m, 1H),
2.85–3.20 (m, 6H); LC–MS m/z 374.1 (MH+), tR 3.24
min. Calcd exact mass for C24H23NO3=373.2.
Compound 1g, N-({4-[2-(4-methoxyphenyl)ethyl]phenyl}
sulfonyl)phenylalanine (0.9 mg, 5%): 1H NMR l 12.80
(bs, 1H), 7.45 (d, 2H), 7.25 (d, 2H), 7.10–7.20 (m, 8H),
6.80 (d, 2H), 3.70 (s, 3H), 3.65 (m, 1H), 2.70–2.90 (m,
6H); LC–MS m/z 440.1 (MH+), tR 3.26 min. Calcd exact
mass for C24H25NO5S=439.2.
cm−1 16
was found to be 1.37 mmol/g or 105% of theoret-
)
ical substitution. Just prior to the reaction with sulfonyl
or carbonyl chloride, the resin was N-Fmoc-deprotected
by treatment with 30% piperidine in DMF (30 min, rt),
washed with DMF (5×), MeOH (3×), DCM (3×), and
MeOH (3×), and dried in vacuo.
Compound 1p, N-({3-[2-(3-nitrophenyl)ethyl]phenyl}
1
sulfonyl)phenylalanine (3.9 mg, 21%): H NMR l 12.75
(bs, 1H), 8.20 (d, 1H), 8.10 (t, 1H), 8.00 (m, 1H), 7.65 (m,
1H), 7.55 (m, 1H), 7.45 (m, 1H), 7.30–7.40 (m, 3H),
7.05–7.20 (m, 5H), 3.80 (m, 1H), 2.80–3.00 (m, 5H), 2.65
(m, 1H); LC–MS m/z 455.0 (MH+), tR 3.17 min. Calcd
exact mass for C23H22N2O6S=454.1.
12. Conversion of 3 to 4 was achieved by treatment with 3
molar equiv. of the appropriate carbonyl or sulfonyl
chloride, plus diisopropylethylamine (3 equiv.), in
dichloromethane with mixing at rt overnight.
Compound
1s,
N-[(4-{2-[4-(acetyloxy)phenyl]ethyl}
13. Each olefin 6 (10 equiv.) was separately treated at 0°C
with 9-BBN (11 equiv.) in THF under argon, and then
the mixtures were allowed to warm to rt, and were mixed
by shaking at rt for 5 h. MicroKans containing 4 were
treated with a solution of triethylamine (10 equiv.) and
PdCl2(dppf) (0.2 equiv.) in degassed DMF/water (9:1).
The olefin/9-BBN reaction mixtures (7) were then added
under argon, the reaction mixtures were capped, and the
mixtures were mixed by orbital shaking at 50°C for 18 h.
The mixtures were then cooled to rt, filtered, washed with
DMF (7×), MeOH (5×), DCM (3×), MeOH (3×), and
DCM (2×), and dried in vacuo. MicroKans were sorted,
and then individually treated with 1:1:0.1 TFA/DCM/
water at rt for 2 h, to release the products 1.
1
phenyl)sulfonyl]phenylalanine (6.0 mg, 32%): H NMR l
12.75 (bs, 1H), 8.20 (d, 1H), 7.45 (m, 2H), 6.95–7.15 (m,
11H), 3.80 (m, 1H), 2.90 (m, 5H), 2.70 (m, 1H), 2.15 (s,
3H); LC–MS m/z 468.1 (MH+), tR 3.16 min. Calcd exact
mass for C25H25NO6S=467.1.
Compound 1u, N-[4-(2-phenylpropyl)benzoyl]phenylala-
1
nine (6.8 mg, 44%): H NMR l 12.70 (bs, 1H), 8.55 (d,
1H), 7.60 (m, 2H), 7.10–7.30 (m, 12H), 4.55 (m, 1H),
2.80–3.20 (m, 5H), 1.15 (d, 3H); LC–MS m/z 388.1
(MH+), tR 3.34 min. Calcd exact mass for C25H25NO3=
387.2.
Compound 1ee, N-({4-[2-(2-quinolinyl)ethyl]phenyl}
1
sulfonyl)phenylalanine (3.9 mg, 21%): H NMR l 12.80
(bs, 1H), 8.40 (d, 1H), 8.20 (d, 1H), 8.00 (m, 2H), 7.80 (t,
1H), 7.60 (t, 1H), 7.55 (d, 1H), 7.40 (m, 2H), 7.30 (m,
2H), 7.00–7.20 (m, 5H), 3.80 (m, 1H), 3.15–3.30 (m, 4H),
2.90 (m, 1H), 2.70 (m, 1H); LC–MS m/z 461.3 (MH+), tR
2.22 min. Calcd exact mass for C26H24N2O4S=460.2.
Compound 1ii, N-{[4-(2-cyclohexylethyl)phenyl]sulfonyl}
14. Proton (1H) nuclear magnetic resonance (NMR) spectra
were measured in DMSO-d6 solution with a General
Electric GN-Omega 400 (400 MHz) spectrometer, using
residual protonated solvent (DMSO l 2.49) as reference
standard. HPLC-electrospray mass spectra (LC–MS)
were obtained using a Finnigan LCQ ion-trap mass spec-
trometer with electrospray ionization, and a YMC Pro
C18 2.0×23 mm column. Gradient elution from 90% A to
95% B over 6 min was used on the HPLC, in which
buffer A was 98% water, 2% acetonitrile and 0.02% TFA,
and buffer B was 98% acetonitrile, 2% water and 0.02%
TFA. Representative examples of isolated products are as
follows:
1
phenylalanine (5.6 mg, 34%): H NMR l 12.75 (bs, 1H),
8.20 (d, 1H), 7.40 (d, 2H), 7.05–7.20 (m, 7H), 3.80 (m,
1H), 2.90 (m, 1H), 2.65 (m, 3H), 1.70 (m, 5H), 1.45 (m,
2H), 1.20 (m, 4H), 0.90 (m, 2H); LC–MS m/z 416.1
(MH+), tR 3.72 min. Calcd exact mass for C23H29NO4S=
415.2.
15. Sieber, P. Tetrahedron Lett. 1987, 28, 6147.
16. Bunin, B. A. The Combinatorial Index; Academic Press:
New York, 1998; p. 219.
Compound 1a, N-[4-(2-phenylethyl)benzoyl]phenylalan-
ine (3.5 mg, 23%): 1H NMR l 12.80 (bs, 1H), 8.60 (d,